GTS Securities LLC Sells 77,352 Shares of Colgate-Palmolive (NYSE:CL)

GTS Securities LLC trimmed its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 78.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 21,743 shares of the company's stock after selling 77,352 shares during the quarter. GTS Securities LLC's holdings in Colgate-Palmolive were worth $1,977,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CL. Chicago Partners Investment Group LLC boosted its stake in Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock worth $591,000 after acquiring an additional 943 shares in the last quarter. Aviva PLC boosted its position in shares of Colgate-Palmolive by 13.4% in the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock worth $88,494,000 after purchasing an additional 114,855 shares in the last quarter. Impact Partnership Wealth LLC purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $803,000. Barclays PLC grew its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Finally, Atlas Legacy Advisors LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at approximately $311,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

CL stock traded down $0.71 on Wednesday, hitting $91.72. The company had a trading volume of 5,265,393 shares, compared to its average volume of 4,685,607. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The stock has a market cap of $74.33 billion, a price-to-earnings ratio of 26.06, a P/E/G ratio of 4.20 and a beta of 0.39. The stock's 50-day simple moving average is $91.90 and its 200 day simple moving average is $91.25.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The firm had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same period last year, the business posted $0.86 EPS. The company's revenue for the quarter was down 3.0% on a year-over-year basis. As a group, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its Board of Directors has approved a share buyback plan on Thursday, March 20th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's management believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.27%. The ex-dividend date of this dividend was Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is 58.76%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Piper Sandler dropped their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Citigroup lifted their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.